Gynecological Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adults
Key facts
- Who runs it
- University Hospital, Bordeaux
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 51 people enrolled
- Started
- 19 Sept 2025
- Ended
- 5 Apr 2026
- Type of study
- Interventional
- Treatments tested
- Questionnaire
- Record updated
- 25 June 2026
Who can take part
- Age
- 18 years to 45 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Women diagnosed with acute leukemia, who underwent allogeneic hematopoietic stem cell transplantation in adulthood (>18 years),
- Aged 20 to 45 at the time of evaluation,
- At least 2 years post-transplant
- French-speaking patients, without comprehension disorders, and literate,
- No objection to participation
Who cannot take part
- Premature ovarian failure prior to management of haemopathy, post-transplant relapse,
- Patient under legal protection
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Gynecological impact and infertility are major issues for women after allogeneic hematopoietic stem cell transplantation.
Read full original descriptionShow less
The aim of the present study is to investigate the prevalence of gynecological complications after allogeneic hematopoietic stem cell transplantation for acute leukemia in adulthood. By conducting a single-center retrospective descriptive analysis, the prevalence, follow-up and treatment of gynecological complications -including premature ovarian failure, vulvovaginal graft-versus-host-disease, cervical pathology- will be analysed
The group in the trial
- QuestionnaireTreatment being tested
A standardized questionnaire was specifically developed for the study to explore: * Women's socio-demographic data * Data about their hematological disease (type of leukemia, conditioning protocol, relapses, graft-versus-host disease etc.) * Information received by patients prior to transplantation concerning gynecological complications * Symptoms, screening, diagnosis and treatment of the main gynecological complications * Patients fertility (spontaneous or after assisted reproductive treatments)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Gynecological and Fertility Impact of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia Diagnosed in Adulthood (GYNEGRAFT)
- Record updated
- 25 June 2026